CCEL.US CryoCell International Inc

Healthcare Health Care Providers & Services USA Stocks
4.85 USD
Close of Nov 13, 2026
2.72 5.45
Market cap
USD 39.1M
P/E
-
P/B
9.72x
ROE
-
Dividend yield
8.26%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Aug 2026.

Is CCEL.US undervalued?

Graham number

The Graham number of CryoCell International Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

CryoCell International Inc fundamental analysis

No fundamental analysis for CryoCell International Inc yet.

CryoCell International Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About CryoCell International Inc

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umb…

Full company profile